Nature Communications

Donor-derived regulatory dendritic cell infusion and early immunosuppressive drug withdrawal in living-donor liver transplantation: a phase I/IIa trial

2026-04-17

Full text

DOI https://doi.org/10.1038/s41467-026-71280-8